Plasma and Intracellular Concentrations in HIV-Infected Patients Requiring Hemodialysis Dosed With Tenofovir Disoproxil Fumarate and Emtricitabine

被引：5
|
作者：
Slaven, James E. [1 ]
Decker, Brian S. [2 ]
Kashuba, Angela D. M. [3 ]
Atta, Mohamed G. [4 ]
Wyatt, Christina M. [5 ]
Gupta, Samir K. [6 ]
机构：
[1] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Div Nephrol, Indianapolis, IN 46202 USA
[3] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr AIDS Res, Chapel Hill, NC USA
[4] Johns Hopkins Sch Med, Div Nephrol, Baltimore, MD USA
[5] Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY 10029 USA
[6] Indiana Univ Sch Med, Div Infect Dis, Indianapolis, IN 46202 USA
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2016年 / 73卷 / 01期
关键词：
PHARMACOKINETICS; TRIAL;
D O I：
10.1097/QAI.0000000000001106
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：e8 / e10
页数：3
相关论文
共 50 条
  • [1] Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients
    Gazzard, BG
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (06) : 793 - 802
  • [2] Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine
    Dumond, Julie B.
    Bay, Camden P.
    Nelson, Julie A. E.
    Davalos, Angel
    Edmonds, Andrew
    De Paris, Kristina
    Sykes, Craig
    Anastos, Kathryn
    Sharma, Roopali
    Kassaye, Seble
    Tamraz, Bani
    French, Audrey L.
    Gange, Stephen
    Ofotokun, Ighovwerha
    Fischl, Margaret A.
    Vance, David E.
    Adimora, Adaora A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [3] Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
    Cid-Silva, Purificacion
    Fernandez-Bargiela, Noelia
    Margusino-Framinan, Luis
    Balboa-Barreiro, Vanesa
    Mena-De-Cea, Alvaro
    Lopez-Calvo, Soledad
    Vazquez-Rodriguez, Pilar
    Martin-Herranz, Isabel
    Miguez-Rey, Enrique
    Poveda, Eva
    Castro-Iglesias, Angeles
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (04) : 479 - 490
  • [4] No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine
    Calza, Leonardo
    Borderi, Marco
    Colangeli, Vincenzo
    Esposito, Fabio
    Giglia, Maddalena
    Bon, Isabella
    Re, Maria Carla
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (01) : 11 - 15
  • [5] Safety of atazanavir/ritonavir with tenofovir disoproxil fumarate in HIV-infected adolescents
    Bunupuradah, T.
    Techasaensiri, C.
    Keadpudsa, S.
    Srimuan, A.
    Sahakijpicharn, T.
    Sriheara, C.
    Thammajaruk, N.
    Prasitsuebsai, W.
    Ananworanich, J.
    Puthanakit, T.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 296 - +
  • [6] The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected Persons
    Fletcher, Courtney V.
    Podany, Anthony T.
    Thorkelson, Ann
    Winchester, Lee C.
    Mykris, Timothy
    Anderson, Jodi
    Jorstad, Siri
    Baker, Jason V.
    Schacker, Timothy W.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (05) : 971 - 975
  • [7] Renal outcomes with efavirenz plus tenofovir disoproxil fumarate/emtricitabine versus other tenofovir disoproxil fumarate-containing antiretroviral regimens among HIV-infected veterans: a national study
    LaFleur, J.
    Bress, A.
    Esker, S.
    Crook, J.
    Nyman, H.
    Bedimo, R.
    Tebas, P.
    Rosenblatt, L.
    [J]. ANTIVIRAL THERAPY, 2016, 21 : A60 - A60
  • [8] Health Care Costs in a Cohort of HIV-Infected US Veterans Receiving Regimens Containing Tenofovir Disoproxil Fumarate/Emtricitabine
    Nelson, Richard E.
    Ma, Junjie
    Crook, Jacob
    Knippenberg, Kristin
    Nyman, Heather
    Paul, Damemarie
    Esker, Stephen
    LaFleur, Joanne
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (10): : 1052 - 1066
  • [9] Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women
    Zhang, William R.
    Scherzer, Rebecca
    Estrella, Michelle M.
    Ascher, Simon B.
    Muiru, Anthony
    Jotwani, Vasantha
    Grunfeld, Carl
    Parikh, Chirag R.
    Gustafson, Deborah
    Kassaye, Seble
    Sharma, Anjali
    Cohen, Mardge
    Tien, Phyllis C.
    Ng, Derek K.
    Palella, Frank J., Jr.
    Witt, Mallory D.
    Ho, Ken
    Shlipak, Michael G.
    [J]. AIDS, 2019, 33 (04) : 723 - 733
  • [10] Fanconi syndrome due to tenofovir disoproxil fumarate reversed by switching to tenofovir alafenamide fumarate in an HIV-infected patient
    Mothobi, Nomvuyo Z.
    Masters, Jeffrey
    Marriott, Deborah J.
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2018, 5 (05) : 91 - 95
12345